Articles dans des revues avec comité de lecture (368)
  1. 70. Gratwohl, A., Ernst, P., Ferrant, A., Frassoni, F., Gahrton, G., Richard, C., Kolb, H. J., Link, H., Niederwieser, D., Ruutu, T., Schattenberg, A., Iacobelli, S., Schmitz, N., Torres-Gomez, A., Zwaan, F. F., Apperley, J. J., Olavarria, E., Kröger, N., Bootsman, N., van Biezen, A., Baldomero, H., Arcese, W., Arnold, R., Bron, D., & Cordonnier, C. (2016). Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study. Annals of hematology, 95(6), 967-972. doi:10.1007/s00277-016-2638-6
  2. 71. Baitar, A., Jerusalem, G., Lobelle, J. P., Flamaing, J., Milisen, K., Wildiers, H., Kenis, C., Moor, R., Decoster, L., Luce, S., Bron, D., Van Rijswijk, R. E. N. R., Rasschaert, M., & Langenaeken, C. (2016). Corrigendum to "Implementation of geriatric assessment-based recommendations in older patients with cancer: A multicenter prospective study" [J. Geriatr. Oncol. 6 (2015) 401-410]. Journal of geriatric oncology, 7(2), 142-143. doi:10.1016/j.jgo.2016.01.005
  3. 72. Najar, M., Raicevic, G., Crompot, E., Fayyad Kazan, H., Bron, D., Toungouz Nevessignsky, M., & Lagneaux, L. (2016). The Immunomodulatory Potential of Mesenchymal Stromal Cells: A Story of a Regulatory Network. Journal of immunotherapy, 39(2), 45-59. doi:10.1097/CJI.0000000000000108
  4. 73. Najar, M., Raicevic, G., Fayyad Kazan, H., Bron, D., Toungouz Nevessignsky, M., & Lagneaux, L. (2016). Mesenchymal stromal cells and immunomodulation: A gathering of regulatory immune cells. Cytotherapy, 18(2), 160-171. doi:10.1016/j.jcyt.2015.10.011
  5. 74. Najar, M., Raicevic, G., Andre, T., Fayyad Kazan, H., Pieters, K., Bron, D., Toungouz Nevessignsky, M., & Lagneaux, L. (2016). Mesenchymal stromal cells from the foreskin: Tissue isolation, cell characterization and immunobiological properties. Cytotherapy, 18(3), 320-335. doi:10.1016/j.jcyt.2015.11.013
  6. 75. Van Damme, M., Crompot, E., Meuleman, N., Maerevoet, M., Mineur, P., Bron, D., Lagneaux, L., & Stamatopoulos, B. (2016). Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance. Clinical Epigenetics, 8, 132. doi:10.1186/s13148-016-0298-y
  7. 76. Buntinx, S., Antoine, P., Bailly, B., Beukinga, I., Bron, D., & De Wilde, V. (2016). PP2.4 IDENTIFYING INFECTIOUS TRIGGERING FACTORS EVEN IN THE PRESENCE OF KNOWN PREDISPOSING DISEASES IS MANDATORY IN HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, A REVIEW OF 35 CASES IN TWO BELGIAN HOSPITALS. Belgian Journal of Hematology, 19-20.
  8. 77. De Witte, T., Baron, F., Suciu, S., Meert, L., Halkes, C. C., Selleslag, D., Bron, D., Amadori, S., Willemze, R., & Muus, P. (2015). Idarubicin and cytarabine in combination with gemtuzumab ozogamicin (IAGO) for untreated patients with high-risk MDS or AML evolved from MDS: a phase II study from the EORTC and GIMEMA Leukemia Groups (protocol 06013). Annals of hematology, 94(12), 1981-1989. doi:10.1007/s00277-015-2486-9
  9. 78. Baitar, A., Jerusalem, G., Lobelle, J. P., Flamaing, J., Milisen, K., Wildiers, H., Kenis, C., Moor, R., Decoster, L., Luce, S., Bron, D., Van Rijswijk, R., Rasschaert, M., & Langenaeken, C. (2015). Implementation of geriatric assessment-based recommendations in older patients with cancer: A multicentre prospective study. Journal of geriatric oncology, 6(5), 401-410. doi:10.1016/j.jgo.2015.07.005
  10. 79. Dubruille, S., Libert, Y., Roos, M., Vandenbossche, S., Collard, A., Meuleman, N., Maerevoet, M., Etienne, A.-M., Reynaert, C., Razavi, D., & Bron, D. (2015). Identification of clinical parameters predictive of one-year survival using two geriatric tools in clinically fit older patients with hematological malignancies: Major impact of cognition. Journal of geriatric oncology, 6(5), 362-369. doi:10.1016/j.jgo.2015.07.006
  11. 80. Bron, D., Dewind, R., Cantinieaux, B., Woff, E., Roelandts, M., Moerman, C., Lemort, M., Heimann, P., De Wilde, V., Meuleman, N., & Maerevoet, M. (2015). Approche pratique des lymphomes: role majeur du médecin généraliste face à l'explosion des nouvelles thérapeutiques. Revue médicale de Bruxelles, 36(4), 237-247.
  12. 81. Bonnet, C., Lejeune, M., Van Kemseke, C., Bron, D., & Beguin, Y. (2015). Prise en charge actuelle du lymphoma de la zone marginale. Revue médicale suisse, 11(483), 1549-1556.
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37     38 Suivant >>